British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2006).
Gazzard
B
B
Chelsea and Westminster Hospital, 369 Fulham Road, London, SW10 9NH, UK. Eileen.witney@chelwest.nhs.uk
Bernard
A J
AJ
Boffito
M
M
Churchill
D
D
Edwards
S
S
Fisher
N
N
Geretti
A M
AM
Johnson
M
M
Leen
C
C
Peters
B
B
Pozniak
A
A
Ross
J
J
Walsh
J
J
Wilkins
E
E
Youle
M
M
D023241:Antiretroviral Therapy, Highly Active / Q000379:methods; D000069454:Darunavir; D018450:Disease Progression; D024882:Drug Resistance, Viral; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000008:administration & dosage*; D006801:Humans; D019429:Integrase Inhibitors / Q000627:therapeutic use; D008297:Male; D009570:Nitriles; D010349:Patient Compliance; D011724:Pyridazines / Q000627:therapeutic use; D011743:Pyrimidines; D019713:Receptors, CCR5 / Q000627:therapeutic use; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage*; D018570:Risk Assessment; D013449:Sulfonamides / Q000627:therapeutic use; D006113:United Kingdom
D017320:HIV Protease Inhibitors; D019429:Integrase Inhibitors; D009570:Nitriles; D011724:Pyridazines; D011743:Pyrimidines; D019713:Receptors, CCR5; D018894:Reverse Transcriptase Inhibitors; D013449:Sulfonamides; C451734:etravirine; D000069454:Darunavir